Driving operational improvements and quality of our services
Learn more
Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas
Learn more
We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.
Download
Our commitment to customer success is embedded in every facet of our operations.
Learn more
Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas
Learn more
Driving operational improvements and quality of our services
Learn moreImproving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search jobs
We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.
Download
Meeting the demands of today’s drug, device and diagnostics development environment requires a next generation service provider.
We offer a range of genomic laboratory services to support drug discovery, precision medicine and clinical development. Our industry-leading team advances research by delivering scientific insights that help clients maximize the value of their data.
Our labs bring expertise in protein production, antibody discovery, and immunogenicity to help you select the most promising candidates and reduce risk as you move toward IND-enabling studies.
One of the world's largest and most respected bioanalytical and ADME laboratory networks. From our global locations, we serve many of the largest pharmaceutical, specialty pharmaceutical and biotechnology companies worldwide.
a CLIA-certified biomarker testing laboratory developing immunoassays used to quantify protein biomarkers in support of drug mechanism of action, pharmacodynamic, prognostic, and predictive clinical studies across all stages of drug discovery and development.
Combining cutting-edge technology platforms and state-of-the-art laboratories with over 35 years of clinical vaccine development.
We have a dedicated Digital Innovation department focused on driving operational improvements and quality of our services. We’ve helped create agile and impactful solutions across the organization with the underpinnings of traceability, productivity, quality, and efficiency.
The immunogenicity team presented a poster at Antibody Engineering and Therapeutics Europe in June 2024. This poster—Early Unwanted Immunogenicity Risk Assessment of Biotherapeutics—discusses our approach to minimizing immunogenicity risks.
Complete the form to view/download this poster.
